FOXO4-DRI FOXO4-DRI is a synthetic peptide designed to selectively disrupt the interaction between FOXO4 and p53, thereby promoting the clearance of senescent cells and supporting tissue rejuvenation
176 Through deacetylation of key molecules such as p53 and LC3, SIRT1 initiates mitochondria-specific autophagy, playing a central role in quality control
Research records need independent documentation because scientific review depends on traceable information
Lower-dose signaling virtually eliminates these issues
Creatine showed a direct linear relationship with D LCO (edf = 1.000, p-value = 0.026), indicating that reduced creatine levels were linked to impaired lung diffusion capacity (Fig
4D), the tumor envelop was found to be intact, with black and white stripes visible on the side of the section